From Rigorous Long-Distance Testing to Music on the Move: OMODA & JAECOO’s Super Hybrid Marathon Reimagines the Road Trip

3iQ Receives In-Principal Approval from Abu Dhabi's IFC

Two Model Premieres, Two Distinct Vibes: OMODA & JAECOO Tease More Surprises for the 2026 Paris Motor Show

SWI Group announces €800 million institutional capital increase at a €6.1 billion final valuation to accelerate the expansion of its...

SWI Group announces €800 million institutional capital increase at a €6.1 billion final valuation to accelerate the expansion of its...

SICC approved scheme of arrangement to allow Jetstar Asia customers to recover unused tickets, bookings, vouchers

SkyAI Announces Intention to Commence Cash Tender Offer to Purchase Common Stock and Pre-funded Warrants at $3.00 Per Share/Pre-funded...

DATA Network joins Sui and Walrus to scale the supply chain for AI training data

DATA Network joins Sui and Walrus to scale the supply chain for AI training data

Real Broker's Leon Chen Launches leonchenre.com for North Atlanta Clients

ATK Phantom Highlights the Evolution of High-Performance Gaming Mice

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Granted FDA Fast Track Designation for First-Line Advanced or Metastatic...

New Independent Economic Study: Sticker Mule Has Generated $2.7 Billion in Economic Impact for New York State and Supported 9,500 Jobs

Blue Purpose Founder Glidewell Secures Third U.S. Patent for Advanced Emergency Response and Communications Technology

FTK FINAL DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Flotek Industries, Inc. Investors to Secure Counsel Before...

Arirang TV, Teams Up with Shindong, Kwon Hyuk-soo and Yujeong to Showcase Gyeongbuk's "Flavors and Charms" to the World!

Rihanna's Golden Dragon Gown has arrived: Guo Pei's Garden of Ethereal Realms Exhibition Opens at China National Silk Museum

ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Duolingo, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class...

Scage Future Provides Business Update on Deliveries, Technology Portfolio and Growth Initiatives; Initiates Regular Investor Communication

InnoCare Announces Approval of Clinical Trial of Bispecific Antibody ICP-B161 Targeting TL1A and IL-23p19 in China